Skip to main content
TipRanks
Go Ultimate75% OFF

Tenet Healthcare (THC) AI Stock Analysis

1,032 Followers
THC

Tenet Healthcare

(NYSE:THC)

Select Model
Rating:83Outperform
Price Target:$340.00â–²(20.54% Upside)
Action:reiterated
Date:11/05/26

The score is driven by strong recent financial performance (notably margins and free cash flow) and a constructive technical uptrend. Valuation is supportive given the low P/E. Offsetting factors are balance-sheet trend discontinuity and earnings-call risks tied to exchange/Medicaid headwinds and nonrecurring Conifer transition benefits.

Positive Factors
Ambulatory growth platformUSPI combines strong margins with expanding higher-acuity procedures and a pipeline of acquisitions, partnerships, and de novo centers. Continued migration toward freestanding ambulatory settings can support durable volume growth, physician engagement, and operating leverage over the next several quarters.
Negative Factors
Exchange and Medicaid exposureTenet remains exposed to policy-driven changes in insurance coverage and Medicaid reimbursement. Reduced exchange participation has already pressured volumes and uncompensated care, while potential work requirements could affect a large admission base and create persistent revenue and margin uncertainty.

Tenet Healthcare Key Performance Indicators (KPIs)

Revenue by SegmentBreaks down income from different business areas, offering insight into which segments are driving growth and profitability. This can reveal strategic focus areas and potential vulnerabilities in the business model.

-$1.00B$0.00$1.00B$2.00B$3.00B$4.00B$5.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Ambulatory Care (USPI) is the durable growth engine—margin and revenue‑per‑case strength plus a shift to higher‑acuity cases underpin the beat-and-raise and justify continued USPI M&A, while Hospital Operations show improving admissions and revenue per admission but remain vulnerable to localized exchange enrollment losses and reimbursement risk. The abrupt removal of Conifer and intersegment eliminations reflects portfolio/accounting changes that clear up consolidated top‑line comparability but introduce timing volatility (supplemental Medicaid/out‑of‑period items); monitor payer mix and rising professional fees as the main downside risks.

Data provided by:The Fly

Tenet Healthcare (THC) vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%30%40%50%60%THC+46.94%SPY+13.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$22.45B
Dividend Yield
―
Average Volume (3M)
778.82K
Price to Earnings (P/E)
8.2
Beta (1Y)
0.81
Revenue Growth
6.23%
EPS Growth
136.09%
Country
US
Employees
88,500
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Tenet Healthcare Business Overview & Revenue Model

Company Description

Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care fac...

How the Company Makes Money

Tenet Healthcare primarily makes money by providing healthcare services that are reimbursed by commercial insurers, government payors (e.g., Medicare and Medicaid), and patients (self-pay). Its revenue model is largely fee-for-service: Tenet bills pa...

Tenet Healthcare Earnings Call Summary

Earnings Call Date:Oct 29, 2026(Q3-2026)|% Change Since:5.05%|Next Earnings Date:Feb 11, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. Tenet delivered substantial earnings, margin, cash flow, and share-repurchase performance; raised its 2026 revenue, EBITDA, and free cash flow guidance; and expressed confidence in core EBITDA growth for 2027. The principal challenges were exchange-related volume and coverage pressure, lower USPI case volumes, the nonrecurring nature of Conifer transition contributions, and uncertainty surrounding Medicaid work requirements, HR 1, and future regulatory conditions.

Positive Updates

Strong Third-Quarter Financial Performance
Third-quarter net operating revenues were $5.6 billion and consolidated adjusted EBITDA was $1.355 billion. Adjusted diluted earnings per share increased 80% year over year to $6.40.

Negative Updates

Lower USPI Case Volumes
USPI same-facility case volumes declined 1.5% year over year, which management said reflected its focus on higher-acuity cases.

Company Guidance

For 2026, Tenet expects consolidated net operating revenues in the range of $22.05 to $22.45 billion, adjusted EBITDA in the range of $5.05 to $5.2 billion, and adjusted free cash flow after NCI in the range of $1.925 to $2.155 billion, including the payment of $150 million in tax payments this year for the Conifer transaction; excluding these tax payments, this would represent $2.2 billion of adjusted free cash flow after NCI at the midpoint of our 2026 outlook. Various transition activities at Conifer are expected to total $450 million of adjusted EBITDA in 2026, and these contributions are not expected to recur in 2027. After excluding the impact of the transition activities at Conifer, Tenet expects its enterprise to deliver overall adjusted EBITDA growth in 2027, assuming the current known regulatory frameworks; USPI should not be materially impacted by exchange headwinds and Medicaid work requirements, with same store revenue growth, consistent margins, and further expansion of the asset portfolio, while the hospital segment currently sees healthy patient demand that would support same store volume growth and a stable operating environment supported by disciplined cost controls.

Tenet Healthcare Financial Statement Overview

Summary

Profitability and cash generation are strong (TTM net margin ~14%, EBITDA margin ~21.6%, TTM FCF ~$3.33B with ~79% FCF-to-net-income conversion). The main offset is balance-sheet trend inconsistency—leverage appears dramatically better in TTM versus prior years, creating durability/quality risk around the step-change.

Income Statement

86Very Positive

Balance Sheet

72Positive

Cash Flow

83Very Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue22.80B21.31B20.66B20.55B19.17B19.48B
Gross Profit6.70B17.53B8.21B7.80B7.05B7.27B
EBITDA5.92B4.48B6.89B3.39B3.08B3.67B
Net Income2.90B1.41B3.20B611.00M411.00M914.00M
Balance Sheet
Total Assets31.59B29.68B28.94B28.31B27.16B27.58B
Cash, Cash Equivalents and Short-Term Investments2.67B2.88B3.02B1.23B858.00M2.36B
Total Debt13.24B13.17B14.33B15.00B15.08B15.65B
Total Liabilities22.00B20.70B20.39B22.80B22.55B23.32B
Stockholders Equity5.44B4.22B4.17B1.61B1.14B1.03B
Cash Flow
Free Cash Flow3.33B2.53B1.12B1.62B321.00M910.00M
Operating Cash Flow4.24B3.54B2.05B2.37B1.08B1.57B
Investing Cash Flow-1.21B-1.27B3.43B-969.00M-808.00M-714.00M
Financing Cash Flow-3.33B-2.40B-3.69B-1.03B-1.78B-936.00M

Tenet Healthcare Technical Analysis

Technical Analysis SentimentPositive
Last Price282.07

Price Trends

50DMA268.84Positive
100DMA253.97Positive
200DMA225.81Positive

Market Momentum

MACD6.04Negative
RSI53.58Neutral
STOCH46.09Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For THC, the sentiment is Positive. The current price of 282.07 is above the 20-day moving average (MA) of 278.39, above the 50-day MA of 268.84, and above the 200-day MA of 225.81, indicating a bullish trend. The MACD of 6.04 indicates Negative momentum. The RSI at 53.58 is Neutral, neither overbought nor oversold. The STOCH value of 46.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for THC.

Tenet Healthcare Risk Analysis

Tenet Healthcare disclosed 25 risk factors in its most recent earnings report. Tenet Healthcare reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.There are risks associated with our current and potential future use of artificial intelligence.Q4, 2024
2.Changes in healthcare laws, regulations and policies could have an adverse effect on our business.Q4, 2024
3.We are subject to operational cybersecurity risks that could materially impact our business.Q4, 2023

Tenet Healthcare Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

THC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
THCTHC83Outperform$22.45B8.1660.60%―6.23%136.09%
UHSUHS76Outperform$11.07B8.0119.54%0.42%8.00%13.14%
ARDTARDT68Neutral$2.50B17.089.48%―2.03%-28.50%
HCAHCA64Neutral$104.69B16.52-100.45%0.61%5.82%16.59%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SGRYSGRY51Neutral$3.51B-40.04-5.17%―2.19%50.06%
CYHCYH44Neutral$284.87M7.57-2.51%―-7.84%-88.93%

* Healthcare Sector Average

Performance Comparison

0%50%100%THCCYHHCAUHSSGRYARDTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
THC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
THCTenet Healthcare Corp.282.0795.3951.10%
CYHCommunity Health Systems2.02-0.92-31.29%
HCAHca Healthcare501.1928.155.95%
UHSUniversal Health Services191.98-32.42-14.45%
SGRYSurgery Partners Inc.26.8511.5575.49%
ARDTArdent Health Partners, Inc.17.759.11105.44%

Tenet Healthcare Corporate Events

Business Operations and StrategyPrivate Placements and Financing

Tenet Healthcare Issues New Senior Notes to Refinance Debt

Positive
Sep 22, 2026

On September 22, 2026, Tenet Healthcare Corporation issued $2 billion of 6.250% senior notes due 2034 under its existing indenture structure with The Bank of New York Mellon Trust Company as trustee. The company plans to use the net proceeds, togethe...

Business Operations and StrategyPrivate Placements and Financing

Tenet Healthcare Announces Major 2034 Senior Notes Offering

Positive
Sep 8, 2026

On September 8, 2026, Tenet Healthcare announced a private placement offering of $1.5 billion in new senior notes due 2034, followed by an upsized and priced $2.0 billion issuance of 6.250% senior notes due 2034. The notes will be unsecured obligatio...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 05, 2026